KROMATID delivers next-generation genomic integrity analysis that reveals structural changes invisible to conventional analysis tools. Get the insight you need to confirm edit precision, ensure safety, and move forward with confidence.
Want to Learn More?
Watch our on-demand webinar as Erin Cross and Daniel O’Connell explore strategies for ensuring genome stability in engineered iPSC lines—and how robust genomic integrity testing supports safer, more reliable CGT development.
Our Applications
We offer a comprehensive suite of analytical services, including efficacy and stability testing, starting material analysis, and drug product characterization. Our expertise ensures rigorous edit validation, method comparison, and batch release testing to support reliable, high-quality cell and gene therapy development.
Drug Product Characterization
Stability and Efficacy Testing
Edit Method Comparison
Edit Validation
Starting Material Analysis/Donor Qualification
Batch Release Testing
What Makes KROMATID Different
What Our Clients Say
Hear from those who have partnered with KROMATID.
A core value of NCH is to prioritize quality and safety so we provide the BEST outcomes for children everywhere. …and it is in partnership with KROMATID that we have evaluated the safety of a FIRST-in-kind Chimeric Antigen Receptor NK-cell therapy for pediatrics.
Nationwide Children's Hospital
Their collaborative approach and innovative solutions have significantly boosted our productivity.
Global Goods Ltd.
We admire Redwood's dedication to sustainability. They help us meet our eco-friendly goals without compromising on quality.
EcoHome Products
KROMASURE™ KBand
KROMASURE™ Band offers access to our comparative reporting and analysis for G-Banding.
